1387 related articles for article (PubMed ID: 25609010)
21. Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers.
Li Y; Miao X; Chen T; Yi X; Wang R; Zhao H; Lee SM; Wang X; Zheng Y
Colloids Surf B Biointerfaces; 2017 Aug; 156():227-235. PubMed ID: 28544957
[TBL] [Abstract][Full Text] [Related]
22. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.
Salarpour S; Forootanfar H; Pournamdari M; Ahmadi-Zeidabadi M; Esmaeeli M; Pardakhty A
Daru; 2019 Dec; 27(2):533-539. PubMed ID: 31317441
[TBL] [Abstract][Full Text] [Related]
24. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
25. Integrated platform for brain imaging and drug delivery across the blood-brain barrier.
Iqbal U; Abulrob A; Stanimirovic DB
Methods Mol Biol; 2011; 686():465-81. PubMed ID: 21082388
[TBL] [Abstract][Full Text] [Related]
26. Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells.
Reynolds JL; Mahajan SD
J Neuroimmune Pharmacol; 2020 Sep; 15(3):554-563. PubMed ID: 31823250
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
28. Upcycling drugs for brain-related diseases: a sustainable future for targeted drug delivery.
de Boer M; Visser CC; Gaillard PJ
Ther Deliv; 2013 Apr; 4(4):435-8. PubMed ID: 23557284
[No Abstract] [Full Text] [Related]
29. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
30. Exosomes Derived from Brain Metastatic Breast Cancer Cells Destroy the Blood-Brain Barrier by Carrying lncRNA GS1-600G8.5.
Lu Y; Chen L; Li L; Cao Y
Biomed Res Int; 2020; 2020():7461727. PubMed ID: 32337272
[TBL] [Abstract][Full Text] [Related]
31. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
[TBL] [Abstract][Full Text] [Related]
33. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation.
Banks WA; Sharma P; Bullock KM; Hansen KM; Ludwig N; Whiteside TL
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575812
[TBL] [Abstract][Full Text] [Related]
34. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
Ché C; Yang G; Thiot C; Lacoste MC; Currie JC; Demeule M; Régina A; Béliveau R; Castaigne JP
J Med Chem; 2010 Apr; 53(7):2814-24. PubMed ID: 20210346
[TBL] [Abstract][Full Text] [Related]
35. Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis.
Arnold J; Schattschneider J; Blechner C; Krisp C; Schlüter H; Schweizer M; Nalaskowski M; Oliveira-Ferrer L; Windhorst S
J Exp Clin Cancer Res; 2020 Sep; 39(1):205. PubMed ID: 32998758
[TBL] [Abstract][Full Text] [Related]
36. Exosomes as Tools to Suppress Primary Brain Tumor.
Katakowski M; Chopp M
Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
[TBL] [Abstract][Full Text] [Related]
37. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
38. Localized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive liposomes.
Bredlau AL; Motamarry A; Chen C; McCrackin MA; Helke K; Armeson KE; Bynum K; Broome AM; Haemmerich D
Drug Deliv; 2018 Nov; 25(1):973-984. PubMed ID: 29688083
[TBL] [Abstract][Full Text] [Related]
39. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
40. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
